How Much Is Optilaser AB Worth?
Optilaser AB - Company Valuation
Combines filings, registry risk signals, and versioned market evidence. Learn More ↗ Opens in a New Tab
Enterprise Value
15,299,043 kr
How This Is Valued
- Capitalised Earnings (EV/EBITDA)
- 15,299,043 kr
- Revenue Multiple
- 19,609,723 kr
- Range
- 12,005,938 kr–20,182,962 kr
- Evidence StrengthShows how strongly available evidence supports the result. Learn More ↗ Opens in a New Tab
- Low
- Based on FY
- 2025
- Valuation Date
- Business StrengthSummarises business strength from financial and public-record signals. Learn More ↗ Opens in a New Tab
- B+
- Altman Z″Indicates financial-distress risk. A higher score is stronger. Learn More ↗ Opens in a New Tab
- 8.26
- Risks
- Insufficient Data
Scope & Evidence
- Company
- Optilaser AB
- Registration
- SE · 5568056708
- Covers
- Not stated in the filing
- Filings Used
- 3 · FY 2025, 2024, 2023
Valuation by Method
Capitalised Earnings (EV/EBITDA)
15.3m kr
Revenue Multiple
19.6m kr
0 kr
5m kr
10m kr
15m kr
20m kr
Industry: NACE 26 · 4 Europe industry cohorts
Methodology & Assumptions
- Maintainable EBITDA
- 964,806 kr
- Industry EV / EBITDA
- 15.9×
- EV / EBITDA Multiple
- 15.9×
- Industry Revenue Multiple
- 3.34×
- Revenue Multiple
- 3.34×
- Enterprise Value
- 15,299,043 kr
- Value Before Discount
- 15,299,043 kr
Key Ratios
- Current RatioCurrent assets divided by current liabilities. Learn More ↗ Opens in a New Tab
- 5.64×
- Quick RatioCurrent assets minus inventory, divided by current liabilities. Learn More ↗ Opens in a New Tab
- 3.67×
- Debt / EquityTotal liabilities divided by equity. Learn More ↗ Opens in a New Tab
- 1.39×
- Equity RatioEquity as a share of total assets. Learn More ↗ Opens in a New Tab
- 41.8%
- Interest CoverageEBIT divided by interest expense. Learn More ↗ Opens in a New Tab
- ≥ 100.00×
- Gross MarginGross profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -
- Net Profit MarginNet profit as a share of revenue. Learn More ↗ Opens in a New Tab
- 14.9%
- Return on EquityNet profit as a share of owners' equity. Learn More ↗ Opens in a New Tab
- 45.3%
- Return on AssetsNet profit as a share of total assets. Learn More ↗ Opens in a New Tab
- 18.9%
- Revenue CAGRAverage annual revenue growth over the available period. Learn More ↗ Opens in a New Tab
- -4.0%
Asset Distribution
Fixed AssetsCashReceivablesInventoriesOther Assets
Liability Maturity
Short-TermLong-Term
3-Year Revenue Scenarios
6m kr
4.5m kr
3m kr
1.5m kr
0 kr
202620272028
OptimisticBaseConservative
A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab
Revenue vs Industry Peers
- Spectro Analytic Irradia Aktiebolag
- 29,848,147 kr
- Omda Predicare AB
- 12,988,780 kr
- Optilaser AB ★
- 5,307,688 kr
- Vigory Active Aktiebolag
- 4,400,000 kr
- Somedic SenseLab AB
- 1,269,366 kr
Earnings before interest, taxes, depreciation, and amortisation. Learn More ↗ Opens in a New Tab
Revenue, Profit & EBITDA
8m kr
6m kr
4m kr
2m kr
0 kr
202320242025
RevenueEBITDANet Profit
Versus Industry Median
6m kr
4.5m kr
3m kr
1.5m kr
0 kr
RevenueNet Profit
This CompanyIndustry Median